Skip to main content

Table 1 Demographic, clinical, laboratory, and ultrasonographic characteristics of the RA patient’ group

From: RETRACTED ARTICLE: Does serum B lymphocyte chemoattractant protein13 (CXCL13) level correlate with parameters of disease activity and severity in rheumatoid arthritis? Clinical and musculoskeletal ultrasonographic assessment

Variables

  

Age (years)

Range (mean ± SD)

19–63 (36.82 ± 13.66)

F/M

No. (%)

37 (74%)/13 (26%)

Disease duration (months)

Range (mean ± SD)

3–12 (8.9 ± 3.09)

MS duration (min) range,

Range (mean ± SD)

15–120 (44.2 ± 27.15)

SJC

Median (IQR)

2 (2–3)

TJC

Median (IQR)

2.5 (2–3)

pVAS (0–10)

Median (IQR)

4 (3–5)

Extra-articular manifestation

(No, %)

18 (36%)

HB (gm/dl)

Mean ± SD

10.7 ± 1.2

Platelet count (× 103/ul)

Mean ± SD

268.4 ± 29.84

ESR, mm/1st h

Mean ± SD

40.26 ± 18.31

CRP, mg/dl

Mean ± SD

13.66 ± 9.89

DAS-28

Range (mean ± SD)

(2.9–6.2) 4.25 ± 0.99

DAS-28

Low

No (%)

7 (13%)

Moderate

31 (62%)

High

12 (24%)

RF-positive

No. (%)

36/50 (72%)

RF titer u/ml

Median (IQR)

16 (8–64)

Anti-CCP Abs-positive

No. (%)

24/50 (48%)

Anti-CCP Abs titer u/ml

Median (IQR)

20 (16.25–56)

Total MSUS score (0–36)

Median (IQR)

8.5 (6–12)

US-SH score (0–18)

Median (IQR)

6 (4–8)

US-PD score (0–18)

Median (IQR)

2 (1–5)

Larsen score (0–100)

Median (IQR)

16 (4.25–20)

Erosion in X-ray

No. of patients (%)

17/50 (34%)

Erosion in US

No. of patients (%)

23/50 (46%)

  1. F female, M male, NO number, MS morning stiffness, SJC number of swollen joints, TJC number of tender joint, p VAS patient global assessment by visual analog scale, HB hemoglobin, ESR/1st h erythrocyte sedimentation rate in the first hour, CRP C-reactive protein, DAS-28 28-joint disease activity score, RF rheumatoid factor, Anti-CCP Abs anti-cyclic citrullinated peptide antibodies, MSUS musculoskeletal ultrasonography, US ultrasound, SH synovial hypertrophy, PD power doppler, SD standard deviation, IQR inter quartile range